Hemorrhagic phase progression with  bruising, nosebleeds, and bleeding at injection sites can be seen. Beginning 4 days after illness and lasting for about two weeks. 

Other clinical signs include: tachycardia, lymphadenopathy, and a petechiae (a rash caused by bleeding into the skin) on internal mucosal surfaces, such as in the mouth and throat, and on the skin. Hepatitis, and severely ill patients may experience rapid kidney deterioration, liver failure or pulmonary failure after 5 days of illness.
